e2v, the innovative solutions provider, has announced that it has signed a new multi-year contract with Accuray Incorporated, based in Sunnyvale, California for the supply of compact modulators and magnetrons for their TomoTherapy® Hi-Art® System, used for the treatment of cancer.
The contract covers a 5 year period for the exclusive supply of magnetrons and a 3 year period for the supply of compact modulators, both from e2v’s RF Power division based in Chelmsford UK. The contract is worth a minimum of £20m.
e2v’s compact modulators and magnetrons represent critical technology within the TomoTherapy Hi-Art System, providing the microwave power which is converted into X-rays for the imaging and radiation treatment of tumours.
The products supplied will be used in new systems and for the on-going support of the worldwide installed base.
Chris Pick, VP of sales at e2v commented ‘We are delighted to be working with Accuray in support of their life enhancing medical systems. This contract is a great example of our partnership approach to forging long term relationships with global industry leaders.”